Because REG reduced the number of TAMs, it was of interest to further investigate REG’s role in CSF1R signaling and the consequences on monocytes and macrophages in peripheral blood (PB) and CRC tumors. The gene discussed is REG1A; the disease is colorectal carcinoma.